Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma - Yang, Shuangshuang; Xu, Jie; Dai, Yuting; Jin, Shiwei; Sun, Yan; Li, Jianfeng; Liu, Chenglin; Ma, Xiaolin; Chen, Zhu; Chen, Lijuan; Hou, Jian; Mi, Jian-Qing; et al. (Nature communications, 2024)
Keywords: 13/21; 13/31; 38/39; 38/77; 38/88; 38/91; 631/250/2504/223/1699; 631/250/251; 631/67/1990/804; 692/308/575; Antigens; Blood cancer; Cell activation; Chimeric antigen receptors; Cytokine Release Syndrome; Cytokines; Cytotoxicity; Humanities and Social Sciences; Humans; Immune system; Immunology; Janus Kinases; Leukocytes (neutrophilic); Lymphocytes; Lymphocytes T; Macrophages; Monocytes; multidisciplinary; Multiple myeloma; Multiple Myeloma - genetics; Multiple Myeloma - therapy; Neutrophil Activation; Neutrophils; Patients; Receptors; Receptors, Chimeric Antigen - genetics; Science; Science (multidisciplinary); Signal Transduction; Signatures; STAT Transcription Factors; Therapy; Toxicity; Transcriptomes